Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)

Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

(2014) John C. Morris et al.   PLoS One

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

(2012) R.M. Anforth et al.   BRITISH JOURNAL OF DERMATOLOGY

Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes

(2012) Maria Davies et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

(2012) Fei Su et al.   NEW ENGLAND JOURNAL OF MEDICINE

Skin Tumors Induced by Sorafenib; Paradoxic RAS-RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1

(2011) J. P. Arnault et al.   CLINICAL CANCER RESEARCH

RASMutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

(2011) Patrick A. Oberholzer et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1

(2011) David R Goudie et al.   NATURE GENETICS

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression

(2010) Lauren Mordasky Markell et al.   CARCINOGENESIS

Keratoacanthoma: Facts and controversies

(2010) Christine J. Ko   CLINICS IN DERMATOLOGY

CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma

(2010) William A. Kanner et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Regulation of epidermal keratinocytes by growth factors

(2010) Yuji Shirakata   JOURNAL OF DERMATOLOGICAL SCIENCE

Keratoacanthoma and Infundibulocystic Squamous Cell Carcinoma

(2009) Steven Kossard et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Homeostatic Role of Transforming Growth Factor-β in the Oral Cavity and Esophagus of Mice and Its Expression by Mast Cells in These Tissues

(2009) Allison Vitsky et al.   AMERICAN JOURNAL OF PATHOLOGY

Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib

(2009) Jean Philippe Arnault et al.   JOURNAL OF CLINICAL ONCOLOGY

The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin

(2009) Damlanur Sakiz et al.   PATHOLOGY RESEARCH AND PRACTICE

Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?

(2008) Antoinette R. Tan et al.   BREAST CANCER RESEARCH AND TREATMENT

TGFβ in Cancer

(2008) Joan Massagué   CELL

Non-Smad pathways in TGF-β signaling

(2008) Ying E Zhang   CELL RESEARCH

Low rates of somatic p53 mutations in keratoacanthomas

(2008) Jeon Dong Suk et al.   JOURNAL OF DERMATOLOGICAL SCIENCE